Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Collaborators Czech Republic: NF Hippokrates, Prague; Denmark: Kræft i Underlivet (KIU); Germany: Stiftung Eierstock Krebs; Greece: K.E.F.I. of Athens; Hungary: Mallow Flower Foundation; Poland: Blue Butterfly Foundation; Serbia: Women’s Center Milica, Kraljevo Public Health Institute; Spain: ASACO Spain; Turkey: Kanserle Dans Dernegi, UK: Ovarian Cancer Action.
Contributors Design, concept, and conduct of the study: EU, MG. Data acqusition, data quality control: MJH, DD,JS, JPG, GI, KZ, CZ, LM, MS, MA, JAL. Data analysis, statistical analysis, and data interpretations: EU, EA-J, MG. Manuscript preparation, editing, and review: EU, EA-J, DC, DQ, CF, MG.
Funding Some funding was awarded by Clovis, MSD and AstraZeneca. This funding is used to pay the data collection company, data entry and analysis, printing paper copies of the survey, and shipping expenses to send surveys to ESGO office in Prague.
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval T.C Izmir Valiligi Izmir Il Saglik Mudurlugu, SBU Izmir Tepecik Egitim ve Arastirma Hastanesi, Toplanti no:1, Karar No: 14.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data are available upon reasonable request.